Acetic acid, 2-[(5-chloro-8-quinolinyl)oxy]-, 1-methylhexyl ester

Acute Toxicity: oral

Administrative data

Endpoint:

acute toxicity: oral

Type of information:

experimental study

Adequacy of study:

key study

Study period:

09.02.1987 to 03.03.1987

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

other: GLP compliant, guideline study, available as unpublished report, no restrictions, fully adequate for assessment

Cross-reference

Reason / purpose for cross-reference:

reference to same study

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

1987

Report date:

1987

Materials and methods

Test guideline

Qualifier:

according to guideline

Guideline:

OECD Guideline 401 (Acute Oral Toxicity)

Deviations:

no

GLP compliance:

yes

Test type:

standard acute method

Limit test:

yes

Test material

Test material information

Constituent 1

Reference substance name:

heptan-2-yl [(5-chloroquinolin-8-yl)oxy]acetate

EC Number:

619-447-3

Cas Number:

99607-70-2

Molecular formula:

C18H22ClNO3

IUPAC Name:

heptan-2-yl [(5-chloroquinolin-8-yl)oxy]acetate

Details on test material:

- Name of test material (as cited in study report): CGA185072 (company code)
- Name of test material (as cited in study report): CGA185072 technical or cloquintocet-mexyl
- Molecular formula (if other than submission substance): not stated
- Substance type:
- Physical state:
- Analytical purity: 91.6%
- Purity test date: not specified
- Lot/batch No.: P. 607001/002
- Expiration date of the lot/batch: not specifed
- Stability under test conditions: not specified
- Storage condition of test material: not specified

Test animals

Species:

rat

Strain:

other: Tif RAIf (SPF), Sprague-Dawley derived

Sex:

male/female

Details on test animals or test system and environmental conditions:

TEST ANIMALS
- Source: Ciba-Geigy Ltd, Animal Production, Sisseln, Switzerland
- Age at study initiation: 7 - 8 weeks
- Weight at study initiation: 162-212g
- Fasting period before study: Not specified
- Housing: conventional laboratory cages
- Diet (e.g. ad libitum): Not specified
- Water (e.g. ad libitum): Not specified
- Acclimation period: 5 days


IN-LIFE DATES: From: 09.02.1987 To: 03.03.1987

Administration / exposure

Route of administration:

oral: gavage

Vehicle:

CMC (carboxymethyl cellulose)

Details on oral exposure:

The test material was admixed to distilled water containing 0.5% CMC and 0.1% polysorbate 80.
The dosing solution was prepared immediately before administration. The stability was therefore not checked. 10 ml of the solution per kg body weight were applied by gastric intubation. The highest dose group received 20 ml/kg body weight due to the poor solubility of the test material.

Doses:

2000 or 5000 mg/kg bw

No. of animals per sex per dose:

Five per sex per group

Control animals:

no

Details on study design:

- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: obsrved hourly for 5 h on day of dosing and twice daily subsequently. Bodyweights recorded pre-test and at weekly intervals
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight

Statistics:

Not applicable - median lethal dose exceeded Guideline limit dose of 2000 mg/kg bw

Results and discussion

Effect levels

Sex:

male/female

Dose descriptor:

LD50

Effect level:

> 2 000 - ca. 5 000 mg/kg bw

Remarks on result:

other: None of the rats dosed at 2000 mg/kg bw died. One of four males dosed at 5000 mg/kg bw died and two of five females.

Mortality:

None of the rats dosed at 2000 mg/kg bw died. One of four males dosed at 5000 mg/kg bw died and two of five females at the higher dose level.

Clinical signs:

Dyspnea, exophthalmus, ruffled fur and curved body positions were observed in all animals. Recovery was evident by day 13.

Body weight:

No information

Gross pathology:

No macroscopic abnormalities noted among rats dosed at 2000 mg/kg bw
Haemorrhagic lungs and stomachs for one male and two females dosed at 5000 mg/kg bw. Intestinal dilation noted for one female

Other findings:

None

Any other information on results incl. tables

One male dosed at 5000 mg/kg bw died on day 2, the two females decedents died on days 1 and 3.

Dose	Mortality	Day of death
2000 mg/kg 5000 mg/kg	0/ 5 1 / 4	day 2
2000 mg/kg 5000 mg/kg	0 / 5 2 / 5	day 1, 3

Applicant's summary and conclusion

Interpretation of results:

not classified

Remarks:

Migrated information Criteria used for interpretation of results: EU

Conclusions:

LD50 greater than 5000 mg/kg bw

Executive summary:

Groups of Tif RAIf (SPF), Sprague-Dawley derived rats were dosed with CGA185072 technical, purity 91.6% at doses of 2000 or 5000 mg/kg test material in 0.5% aqueous CMC and 0.1% polysorbate 80.The animals were assessed daily for the following 14 days for any signs of systemic toxicity and their bodyweights recorded at intervals throughout the study.After 14 days surviving rats were sacrificed and subjected to gross necropsy as were those rats which died spontaneously. Dyspnea, exophthalmus, ruffled fur and curved body positions were observed in all animals. At 5000 mg/kg bw one male and two females died. Surviving animals recovered within 13 days. At necropsy, no macroscopic abnormalities were found at 2000 mg/kg. At 5000 mg/kg one male and 2 females showed hemorrhagic lungs and a hemorrhagic stomach. The small intestine of one female was dilated.

The acute oral LD50 of CGA185072 tech. is greater than 5000 mg/kg in male and female rats.